Advanced Wound Care · Drug-Device Combination · A2014
Omeza OCM™
Heal Wounds That
Won’t Respond.
When standard care stalls — debridement, compression, alginates, collagen — OCM™ is what comes next. A first-of-its-kind drug‑device combination matrix that works across all phases of wound healing. Reduces MRSA by 99.98%. No refrigeration. No special equipment. Once weekly.
-
Decrease InflammationPharmaceutical-grade time-released elements migrate into wound tunnels and crevices.
-
Increase ProliferationSupports cellular proliferation and tissue regeneration across all healing phases.
-
Reduce Biofilm ImpactAntimicrobial components — no risk of bacterial resistance or cytotoxicity.
-
Support RemodelingAbsorbable, biodegradable scaffold provides a full physical barrier throughout healing.
A2014
Product Code
9+
Wound Indications
1×
Single-Use Vial
1/wk
Typical Application
20K+
GSE Clients Served
Request Product Info
Get pricing, samples & reimbursement info within 1 business day.
🔒 Your information is secure and never shared.
By submitting you agree to our Privacy Policy & Terms of Use.
By submitting you agree to our Privacy Policy & Terms of Use.
You're All Set!
A GSE specialist will reach out within 1 business day with Omeza OCM™ pricing and information.
Drug-Device Combination Product
Sterile Single-Use Vials
Ships 1–2 Business Days
Wholesale Pricing Available
Dedicated Account Rep
Medicare Reimbursable (A2014)
Is This You?
OCM™ Was Built for Cases Like Yours
🩹
Chronic Wounds That Won’t Heal
Your patient has a wound that has stalled for weeks or months despite standard care. Debridement, compression, alginates — nothing is working. OCM™ is specifically designed for hard-to-heal, non-responding wounds.
Request Info →
🦺
Podiatrists & Wound Care Clinics
You treat diabetic foot ulcers, venous leg ulcers, and pressure wounds weekly. OCM™ integrates directly into your existing protocol — no special equipment, no refrigeration, once-weekly application.
Request Info →
🧉
Reduce Healing Time in Diabetic Ulcers
Clinical data shows OCM™ reduces wound area by 60%+ in 4 weeks in real-world patient populations, including patients with serious comorbidities typically excluded from clinical trials.
Request Info →
Product Overview
What Is Omeza OCM™?
Omeza OCM™ (A2014) is a novel, proprietary wound matrix — an anhydrous solid scaffold containing cold water-fish peptides and non-cytotoxic antimicrobial components designed to support every stage of wound healing.
Decrease Inflammation
Pharmaceutical-grade time-released elements migrate into wound tunnels and crevices to reduce the inflammatory response.
Increase Proliferation
Supports cellular proliferation and tissue regeneration, accelerating the wound through the healing process.
Reduce Biofilm Impact
Contains antimicrobial components known to reduce biofilm formation and protect the wound environment.
Support Remodeling
Absorbable and biodegradable scaffold supports the final remodeling phase with a full-wound physical barrier.
Clinical Indications
Indicated Wound Types
Omeza OCM™ is indicated for the management of a broad range of acute and chronic wounds across multiple care settings.
- Partial & Full-Thickness Wounds
- Pressure Ulcers
- Venous Ulcers
- Diabetic Ulcers
- Chronic Vascular Ulcers
- Tunneled / Undermined Wounds
- Surgical Wounds
- Trauma Wounds
- Draining Wounds
Read full instructions for use before applying. Download Full IFU →
Packaging & Ordering
How Is OCM™ Supplied?
Omeza OCM™ is available in single-dose pouches and commercial cartons. Contact GSE for wholesale pricing and availability.
| Description | Packaging | UDI Number | Availability |
|---|---|---|---|
| OCM™ | Single-dose pouch (includes IFU) | 859839007014 | Not commercially available |
| OCM™ 4-Pack | 4-pk carton (4 pouches) | 859839007038 | ✓ For commercial sale |
| OCM™ 10-Pack | 10-pk carton (4 pouches) | 859839007212 | ✓ For commercial sale |
Clinical Evidence
Real-World Case Study
54-year-old male with a 152+ day old venous leg ulcer (VLU), HTN, Factor V Leiden Deficiency, DVT, and active smoker. Treated with Omeza OCM™.
Week 1 — Initial Presentation
Status at Treatment Start
152+ day chronic VLU with active inflammation, significant biofilm burden, and multiple complicating comorbidities including DVT and Factor V Leiden deficiency.
Week 5 — Proliferation Phase
Measurable Progress
Significant reduction in wound size and inflammation. OCM™ scaffolding actively supporting tissue proliferation and biofilm reduction across the wound bed.
Week 11 — Remodeling Phase
Advanced Wound Closure
Substantial closure achieved on a wound chronic for 152+ days. Continued progression through the remodeling phase with OCM™ supporting the final healing stages.
Clinical Evidence
Proven Clinical Outcomes
Real-world multi-center clinical data demonstrating OCM™’s effectiveness across a broad patient population — including high-comorbidity patients typically excluded from controlled trials.
60%+
Wound Area Reduction
Average wound area reduction in 4 weeks across real-world patient populations with multiple comorbidities.
82%
Mean Area Reduction
Mean percent area reduction upon completion in a 3-case series, with 2 of 3 cases achieving complete closure.
111
Patients Enrolled
Multi-center clinical study across DFUs, VLUs, pressure injuries, surgical wounds, and other wound types.
4wk
Biofilm Clearance
Complete tissue-negative fluorescence achieved within 4 weeks in peer-reviewed case series data.
Clinical Documentation
Download Clinical Outcomes & Sales Brochure
Access the full OCM™ sales brochure, instructions for use, and peer-reviewed clinical data to share with your team.
See It in Action
Omeza OCM™ Videos
Watch how OCM™ works and hear from a real patient whose life was changed by this treatment.
How To Apply
Clinical Overview
What Physicians Are Saying
Physician Testimonials
Wound care specialists, podiatrists, and medical directors across the country have seen remarkable results with Omeza OCM™.
★★★★★
“Omeza collagen matrix is easily applied, easily maintained and nearly every patient with whom we’ve used it has gone on to improvement or full healing within the 3rd or 4th application. I will plan to use it regularly on my wound patients.”
Randall Kline, DPM, FACFAS, FAPWCA
Allied Bone and Joint
★★★★★
“After the first two treatments, I was most impressed by the positive qualitative change to the wound bed with robust granulation tissue forming. Over the next three treatments, the wound quickly epithelialized and was healed.”
Dr. Michael Lacqua, MD MBA
Medical Director, Center for Wound Healing, Richmond University Medical Center
★★★★★
“After 37 years of wound care experience, having tried everything in a wound care center setting, I can only suggest… drop what you are using and try Omeza. The results are astounding. The simplicity of application and alleviation of patient responsibility cannot be overstated.”
Gregory A. Black, DPM
Sylvania Podiatry, Sylvania, Ohio
★★★★★
“Variable application concept, lidocaine, collagen (matrix), skin protectant, with an easy application process. Amazing results for my patients with chronic non healing wounds!”
Dr. Anthony J. LaLama
Foot and Ankle Surgeon, Wound Care Specialist, Premier Foot & Ankle
★★★★★
“After about three months of using Omeza, I can finally say my patient’s wound is healed. After one week post application, I noticed a significant reduction in edema, wound size and increased epithelialization.”
Oscar Rojas, DPM
Barry University Foot and Ankle Institute, Miami, FL
★★★★★
“The response to the Omeza treatment protocol was greater than expected and healed 3 wounds that were present for greater than a year. Skeptical nurses are now demanding it for our tough stasis dermatitis patients.”
Carmen Hudson, MD, FACS, CWSP
Medical Director, United Wound Healing
Complete Your Protocol
Wound Care Bundles from GSE
OCM™ works best as part of a complete wound care protocol. GSE Medical Supplies offers everything you need — bundled for convenience and priced for wholesale.
Gloves Bundle
Nitrile, latex, and vinyl exam gloves in bulk quantities. Essential PPE for every wound care procedure, available in all sizes from GSE at wholesale pricing.
Get Bundle Pricing
Dressings Bundle
Advanced foam dressings, gauze, tapes, and wound care kits to complete your OCM™ protocol. Cover and protect the wound bed post-application for optimal outcomes.
Get Bundle Pricing
Disinfectants Bundle
Surface disinfectants, wound prep supplies, and infection control products to maintain a clean clinical environment before and after OCM™ application.
Get Bundle Pricing
Ideal Candidates
Who Should Use Omeza OCM™?
OCM™ is a versatile wound matrix indicated for a wide range of practice types treating chronic and hard-to-heal wounds.
Podiatry Practices
Diabetic foot ulcers and lower extremity wounds that have failed to respond to standard care protocols — OCM™ is purpose-built for these presentations.
Talk to a Specialist →
Wound Care Clinics
Outpatient wound care centers treating VLUs, pressure injuries, and chronic non-healing wounds. Simple weekly application fits directly into existing clinical workflows.
Talk to a Specialist →
Dermatology
Post-surgical wounds, skin tears, and chronic skin conditions including stasis dermatitis. OCM™ provides a physical barrier and antimicrobial environment supporting tissue repair.
Talk to a Specialist →
Surgical Centers
Post-operative wound dehiscence, donor sites, and post-procedure wounds. Compatible with NPWT and HBOT. No special equipment or refrigeration required.
Talk to a Specialist →
Home Health & SNFs
Single-use disposable vial format makes OCM™ ideal for home health wound care visits and skilled nursing facilities treating pressure injuries.
Talk to a Specialist →
Hospitals & Health Systems
GPO pricing available through NuEdge Alliance, Vizient, and Provista. Ideal for health systems looking for a comprehensive wound matrix at institutional pricing.
Talk to a Specialist →
Why Order Through GSE
The GSE Advantage
GSE Medical Supplies is an authorized distributor with a proven track record serving 20,000+ healthcare clients — bringing wholesale pricing and dedicated service to Omeza OCM™.
20K+
Healthcare Clients
Trusted by over 20,000 healthcare providers and facilities across the United States.
1–2
Day Fulfillment
Orders typically processed and shipped within 1–2 business days with reliable nationwide delivery.
GPO
Group Purchasing
NuEdge Alliance GPO distributor with Vizient and Provista access for competitive institutional pricing.
WOB
Women-Owned · Est. 2020
Certified Women-Owned Business and proud HIDA member, headquartered in Orlando, FL.
Have Questions?
Frequently Asked Questions
Common clinical questions about OCM™ answered. For additional information, contact a GSE specialist.
What is OCM™?
OCM™ is a novel, proprietary wound matrix — an anhydrous solid comprised of peptides, omega fatty acids, nutrients, and plant-derived oils and waxes. It supplements new granulation tissue, stimulates re-epithelialization, and supports remodeling. In clinical studies at the University of Miami, OCM™ reduced MRSA bacterial counts by 99.98% and Pseudomonas aeruginosa by >98%.
Is OCM™ a solid, hydrogel, or liquid?
OCM™ is an amorphous solid. It is not a liquid or gel. It warms to body temperature after application and becomes more malleable, conforming to the wound bed.
How is OCM™ applied?
Apply directly to the wound bed in strips. Once warmed to body temperature, spread across the wound surface with an applicator such as a tongue depressor. Cover with a non-adherent (petrolatum-based, xeroform, or silicone) dressing. A secondary absorptive dressing is recommended for wounds with high exudate.
Can OCM™ be applied to tunneling wounds?
Yes. OCM™ may be applied to tunneling wounds and over exposed bones and tendons. The amount applied will depend on the depth of the tunnel. There are no contraindications for use in deep or tunneling wounds.
What is the dosing recommendation?
Frequency of application is determined by the managing clinician. The recommended maximum is no more than 4 applications per week. Typical application frequency is once weekly. Professional clinical judgment should direct care.
How is OCM™ different from other wound care products?
OCM™ can be applied at any time, unlike skin substitutes that require a 4-week wait period. It has multimodal mechanisms of action — most wound care products have a single mechanism. This makes it uniquely suited for hard-to-heal, stalled wounds.
Is OCM™ anti-bacterial / anti-microbial?
Yes. In vitro and in vivo studies at the University of Miami demonstrated significant antibacterial effects against MRSA and Pseudomonas. The OCM™ formulation also creates an environment that is not supportive to microorganism survival, as bacteria need water to survive.
Can micro-organisms become resistant to OCM™?
It is highly unlikely. OCM™ is not an antibiotic. It has multiple natural antimicrobial mechanisms of action, unlike antibiotics which typically have a single mechanism. This makes resistance far less likely.
Is OCM™ cytotoxic?
No. The components of OCM™ are naturally occurring and non-toxic. Safety testing shows no evidence of toxicity, sensitization, or irritation.
Can OCM™ be used on infected wounds?
Yes. In the case of clinical infection, concomitant use of appropriate antibiotics per identified organisms and medical guidelines is recommended under the direction of the attending clinician.
What dressings should be avoided with OCM™?
Avoid calcium alginates and products containing silver, iodine (e.g. Iodosorb), or alcohol (e.g. Hydrofera Blue). These may alter the chemistry of the OCM™ formulation. OCM™ should be used without other biocides or antiseptics.
How should a wound be prepared before applying OCM™?
Clean and prepare the wound bed. Ensure it is dried well after cleansing before applying OCM™. Sharp debridement prior to application is recommended as the gold standard for chronic wound management, though OCM™ may be applied where debridement is not required.
Can OCM™ be used with NPWT or Hyperbaric Oxygen Therapy?
Yes to both. For NPWT, allow at least 30 minutes for OCM™ to absorb before applying the negative pressure dressing. For HBOT, apply OCM™ at the conclusion of the last HBO treatment each week to optimize absorption.
Does OCM™ have a fish allergy concern?
Fish allergy is a reaction to the protein parvalbumin. Shellfish allergy involves tropomyosin. Neither protein is present in OCM™. As hypersensitivity and allergic reactions vary, discretion of both provider and patient is recommended.
Can OCM™ be used on multiple wounds on the same patient?
Yes. Using the same unit dose package on multiple wounds on the same patient during the same visit is permissible. However, the same package cannot be used across multiple patients.
How large an area can a single application cover?
Each unit dose contains approximately 18 cm² of product — roughly equivalent to a 3x3 or 4x4 dressing. Due to wound variability in shape and depth, actual coverage may vary.
Are the ingredients Kosher and Halal certified?
Yes. OCM™ is manufactured from the skins of kosher fish and meets strict Kosher and Halal standards. Ingredients are sustainably sourced and meet the purity requirements of the US, European, and Japanese Pharmacopoeia. No genetically modified materials are used.
Have more questions?
Contact a GSE Medical Supplies specialist for clinical support, pricing, and availability of OCM™ for your practice.
Talk to a Specialist →
⚠ Important Disclaimer: Providers are strongly advised to adhere to all CMS and State Medical Coverage (SMC) guidelines when using OCM™. All applications must demonstrate medical necessity, include proper documentation, and follow current Local Coverage Determinations (LCDs) for DFU and VLU to ensure compliant billing. These recommendations do not apply to the inpatient hospital setting.
Your Patients Can’t Wait.
Neither Should You.
Get wholesale pricing, product samples, and reimbursement support for OCM™ (A2014) — backed by GSE’s dedicated account team and 1–2 day fulfillment.
Distributed By
Product By
A Division of Global Supply Exchange · Orlando, FL 32827
© 2025 Global Supply Exchange LLC · GSE Medical Supplies
HIDA Member · NuEdge Alliance · Vizient & Provista GPO · Women-Owned Business